We are live on ! Find out more
KFS

Kurt F. Somerville Portfolio holdings

AUM $379M
1-Year Est. Return 19.42%
This Fund
S&P 500
This Quarter Est. Return
+0.27%
1 Year Est. Return
+19.42%
3 Year Est. Return
+62.7%
5 Year Est. Return
+83.65%
10 Year Est. Return
+302.17%
AUM
$440M
AUM Growth
+$37.9M
Cap. Flow
+$38.2M
Cap. Flow %
8.7%
Top 10 Hldgs %
34.84%
Holding
134
New
4
Increased
59
Reduced
28
Closed
3

Top Buys

Rank Stock Value
1
CVS icon
CVS Health
CVS
+$1.96M
2
NVS icon
Novartis
NVS
+$1.78M
3
PG icon
Procter & Gamble
PG
+$1.6M
4
ATR icon
AptarGroup
ATR
+$1.53M
5
AAPL icon
Apple
AAPL
+$1.46M

Top Sells

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$1.89M
2
LH icon
Labcorp
LH
+$1.23M
3
PEP icon
PepsiCo
PEP
+$382K
4
CYN
CITY NATIONAL CORPORATION
CYN
+$375K
5
STT icon
State Street
STT
+$374K

Sector Composition

Rank Sector Weight
1 Technology 24.39%
2 Healthcare 22.5%
3 Industrials 17.9%
4 Energy 9.03%
5 Consumer Staples 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABT icon
26
Abbott
ABT
$187B
$7.07M 1.61%
152,689
+23,059
+18% +$1.06M
MSFT icon
27
Microsoft
MSFT
$2.92T
$6.7M 1.52%
164,818
+16,962
+11% +$738K
PRGO icon
28
Perrigo
PRGO
$1.43B
$6.47M 1.47%
39,100
+3,950
+11% +$630K
IPGP icon
29
IPG Photonics
IPGP
$3.57B
$6.43M 1.46%
69,340
+9,915
+17% +$856K
HP icon
30
Helmerich & Payne
HP
$3.31B
$5.84M 1.33%
85,748
+18,540
+28% +$1.21M
TGT icon
31
Target
TGT
$65.5B
$5.58M 1.27%
68,004
+8,680
+15% +$670K
CSCO icon
32
Cisco
CSCO
$456B
$5.35M 1.22%
194,490
+10,302
+6% +$290K
PBA icon
33
Pembina Pipeline
PBA
$29B
$4.6M 1.05%
145,250
+24,825
+21% +$799K
ABB
34
DELISTED
ABB Ltd
ABB
$3.69M 0.84%
174,225
+18,655
+12% +$384K
XLNX
35
DELISTED
Xilinx Inc
XLNX
$3.63M 0.83%
85,880
+27,150
+46% +$1.11M
GE icon
36
GE Aerospace
GE
$377B
$3.15M 0.72%
26,438
+897
+4% +$107K
ILMN icon
37
Illumina
ILMN
$29.2B
$3M 0.68%
16,608
+2,251
+16% +$424K
STT icon
38
State Street
STT
$50.2B
$2.77M 0.63%
37,679
-5,000
-12% -$374K
GIS icon
39
General Mills
GIS
$20.1B
$2.65M 0.6%
46,723
+16,300
+54% +$869K
MRK icon
40
Merck
MRK
$326B
$2.58M 0.59%
47,067
+8,313
+21% +$471K
XYL icon
41
Xylem
XYL
$29.7B
$2.27M 0.52%
64,923
+14,725
+29% +$519K
IBM icon
42
IBM
IBM
$214B
$2.25M 0.51%
14,641
-1,004
-6% -$152K
ABBV icon
43
AbbVie
ABBV
$465B
$1.87M 0.43%
32,000
+5,400
+20% +$326K
IONS icon
44
Ionis Pharmaceuticals
IONS
$9.14B
$1.83M 0.42%
28,762
+4,100
+17% +$278K
SPY icon
45
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$1.67M 0.38%
8,100
PFE icon
46
Pfizer
PFE
$144B
$1.66M 0.38%
50,339
-211
-0.4% -$6.71K
CL icon
47
Colgate-Palmolive
CL
$74.2B
$1.66M 0.38%
23,910
-152
-0.6% -$10.5K
DE icon
48
Deere & Co
DE
$173B
$1.65M 0.38%
18,875
+1,400
+8% +$124K
UNFI icon
49
United Natural Foods
UNFI
$3.07B
$1.52M 0.35%
19,762
+4,840
+32% +$379K
UNP icon
50
Union Pacific
UNP
$175B
$1.49M 0.34%
13,716
-1,000
-7% -$117K

Similar funds

Kurt F. Somerville's Q1 2015 Portfolio in Review

As of Q1 2015, Kurt F. Somerville held 134 positions worth $440M, up 9.4% from $402M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Kurt F. Somerville deployed $38.2M of net new capital in Q1 2015, opening 4 new positions and adding to 59 existing holdings. Its largest new stake was Costco: 1,490 shares worth $226K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Labcorp, an estimated $1.23M trimmed.

  • Kurt F. Somerville's largest Q1 2015 buy was Costco: 1,490 shares worth $226K.
  • Kurt F. Somerville added most to CVS Health in Q1 2015, an estimated $1.96M increase.
  • Kurt F. Somerville's biggest Q1 2015 reduction was Labcorp, cutting an estimated $1.23M.
  • Kurt F. Somerville fully exited CDK Global, Inc. in Q1 2015, selling an estimated $1.89M.
  • Kurt F. Somerville's ten largest holdings make up 35% of its $440M portfolio in Q1 2015.
  • Kurt F. Somerville opened 4 new positions and closed 3 in Q1 2015.
  • Kurt F. Somerville's portfolio value rose 9.4% quarter-over-quarter to $440M.

Based on Kurt F. Somerville's 13F filing for Q1 2015, filed 22 May 2015.